Bogart Wealth LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.4K | Hold |
35
| – | – | ﹤0.01% | 765 |
|
2025
Q1 | $9.45K | Buy |
35
+4
| +13% | +$1.08K | ﹤0.01% | 758 |
|
2024
Q4 | $7.3K | Hold |
31
| – | – | ﹤0.01% | 795 |
|
2024
Q3 | $8.53K | Sell |
31
-5
| -14% | -$1.38K | ﹤0.01% | 729 |
|
2024
Q2 | $8.75K | Hold |
36
| – | – | ﹤0.01% | 696 |
|
2024
Q1 | $5.38K | Hold |
36
| – | – | ﹤0.01% | 752 |
|
2023
Q4 | $6.89K | Hold |
36
| – | – | ﹤0.01% | 689 |
|
2023
Q3 | $6.38K | Hold |
36
| – | – | ﹤0.01% | 672 |
|
2023
Q2 | $6.84K | Hold |
36
| – | – | ﹤0.01% | 646 |
|
2023
Q1 | $7.21K | Hold |
36
| – | – | ﹤0.01% | 650 |
|
2022
Q4 | $8.56K | Hold |
36
| – | – | ﹤0.01% | 582 |
|
2022
Q3 | $7K | Hold |
36
| – | – | ﹤0.01% | 616 |
|
2022
Q2 | $5K | Hold |
36
| – | – | ﹤0.01% | 625 |
|
2022
Q1 | $6K | Hold |
36
| – | – | ﹤0.01% | 543 |
|
2021
Q4 | $6K | Hold |
36
| – | – | ﹤0.01% | 525 |
|
2021
Q3 | $7K | Hold |
36
| – | – | ﹤0.01% | 495 |
|
2021
Q2 | $6K | Hold |
36
| – | – | ﹤0.01% | 487 |
|
2021
Q1 | $5K | Buy |
+36
| New | +$5K | ﹤0.01% | 461 |
|